Shuttle Pharmaceuticals Holdings (SHPH) Liabilities and Shareholders Equity (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $11.8 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 122.39% year-over-year to $11.8 million; the TTM figure through Mar 2026 stood at $31.3 million (up 177.21% YoY), while the FY2025 annual figure was $10.5 million, up 317.99% from the prior year.
• Liabilities and Shareholders Equity was $11.8 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $10.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $11.8 million in Q1 2026 to a low of $673568.0 in Q3 2024.
• Historically, Liabilities and Shareholders Equity has averaged $6.5 million across 5 years, with a median of $6.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 1227.96% in 2022, then sank 90.87% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $8.7 million in 2022, then tumbled by 31.22% to $6.0 million in 2023, then sank by 57.89% to $2.5 million in 2024, then jumped by 317.99% to $10.5 million in 2025, then gained by 12.73% to $11.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $11.8 million (Q1 2026), $10.5 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.